IP Library Granted Patent US 7,605,146
Granted Patent B2
US 7,605,146 · App. 09/971,929 · Granted Oct 20, 2009

Process for producing an amide compound

Assignee: Nihon Medi-Physics Company, Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,605,146
App. No.
09/971,929
Granted
Oct 20, 2009
Kind
B2
Abstract

There is disclosed a process for producing an amide compound, which process is characterized in that a compound having an amino group are reacted with a polyaminopolycarboxylic acid anhydride in the presence of the polyaminopolycarboxylic acid.

Claims (37)

1. A process for producing an amide compound, which comprises reacting a compound having an amino group with a polyaminopolycarboxylic acid anhydride in the presence of the polyaminopolycarboxylic acid,

wherein the polyaminopolycarboxylic acid anhydride is added to a mixture of the compound having an amino group and the polyaminopolycarboxylic acid, or the compound having an amino group and the polyaminopolycarboxylic acid anhydride are added to the polyaminopolycarboxylic acid,

wherein the polyaminopolycarboxylic acid anhydride is ethylenediaminetetraacetic dianhydride, ethylenediaminetetraacetic acid monoanhydride, diethylenetriaminepentaacetic acid dianhydride, 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic dianhydride, or 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid monoanhydride; and

wherein the polyaminopolycarboxylic group of both said acid and said acid anhydride are the same.

2. The process according to claim 1 , wherein the compound having an amino group is a protein, a peptide, an amino acid, an amino sugar or an amine.

3. The process according to claim 2 , wherein the amino sugar is an amino oligosaccharide or an amino oligosaccharide having a reduced terminal reducing group.

4. The process according to claim 3 , wherein the molecular weight of the amino oligosaccharide is 500 to 2000.

5. The process according to claim 4 , wherein the amino oligosaccharide having a molecular weight of 500 to 2000 is a glucosamine oligosaceharide or a galactosaniino oligosaceharide.

6. The process according to claim 5 , wherein the galactosamino oligosaccharide is a galactosamine tri- to deca-saccharide.

7. The process according to claim 1 , wherein the polyaminopolycarboxylic acid anhydride is added to a mixture of the compound having an amino group and the polyaminopolycarboxylic acid.

8. The process according to claim 1 , wherein the compound having an amino group and the polyaminopolycarboxylic acid anhydride are added to the polyaminopolycarboxylic acid.

9. The process according to claim 8 , wherein the compound having an amino group and the polyaminopolycarboxylic acid anhydride are added simultaneously to the polyaininopolycarboxylic acid.

10. The process according to claim 1 , wherein the reaction is performed in the presence of a solvent.

11. The process according to claim 10 , wherein the solvent is at least one selected from the group consisting of water and an organic solvent.

12. The process according to claim 11 , wherein the solvent is water.

13. The process according to claim 1 , wherein the compound having an amino group is a chitosan tri- to deca-saccharide, a chitosan tri- to deca-saccharide having a reduced terminal reducing group, a galactosamine tri- to deca-saccharide, a galactosamine tri- to deca-saccharide having a reduced terminal reducing group, serum albumin, fibrinogen, galactosyl serum albumin, amylase, pepsin, IgG, Fab, Fab′, thyroid-stimulating hormone, a growth hormone, prolamine, glutelin, Pyr-Lys-Arg-Pro-Ser-Gln-Arg-Ser-Lys-Tyr-Leu (SEQ ID NO:1), D-Phe-octreotide, polylysine, oxytocin, bradykinin, valinomycin, colistin, an α-amino acid, a β-amino acid, a γ-amino acid, aniline, 4-methylaniline, 4-octylaniline, ethylamine, n-propylamine, isopropylamine, n-butylamine, sec-butylamine, isobutylamine, tert-butylamine, n-octylamine, n-decylamine, (1-naphthylmethyl)amine, N-methylaniline, N-methyl-4-ethylaniline, N-methyl-4-octylaniline, diethylamine, N-ethyl-N-propylamine, ethylene diamine, dansylethylenediamine, dansyihexamethylenediamine, N-(1-naphthyl)ethylenediamine, 1-naphthalenesulfonylethylenediamine, hexamethylenediamine, or phenylenediamine.

14. The process according to claim 1 , wherein the amide compound is a conjugate of a human serum albumin and diethylenetriaminepentaacetic acid,

a conjugate of galactosyl serum albumin and diethylenetriamine-pentaacetic acid,

a conjugate of D-Phe-octreotide and diethylenetriamine-pentaacetic acid,

an amide compound of formula (1),

an amide compound of formula (4),

an amide compound of formula (5),

an amide compound of formula (6),

an amide compound of formula (7),

an ainide compound of formula (8),

N-(phenylcarbamoylmethyl)diethylenetriamine-N,N′,N″,N″-tetraacetic acid, N-(4-octylphenylcarbamoylmethyl)ethylenediamine-N,N″,N″-triacetic acid, N-(4-octylphenylcarbamoylmethyl)diethylenetriamine-N,N′,N″,N″-tetraacetic acid, N-[(6-dansylaminohexyl)carbamoylmethyl]diethylenetriamine-N,N′,N″,N″-tetraacetic acid, or N,N″-bis(phenylcarbamoylmethyl)diethylenetriamine-N,N′,N″-triacetic acid.

15. A process for producing an amide compound, which comprises reacting a compound having an amino group with a polyaminopolycarboxylic acid anhydride in the presence of the polyaminopolycarboxylic acid; wherein the compound having an amino group is a chitosan tri- to deca-saccharide,

wherein the polyaminopotycarboxylic acid anhydride is added to a mixture of the compound having an amino group and the polyaminopolycarboxylic acid, or the compound having an amino group and the polyaminopolycarboxylic acid anhydride are added to the polyaminopolycarboxylic acid,

wherein the polyaminopolycarboxylic acid anhydride is ethylenediaminetetraacetic dianhydride, ethylenediaminetetraacetic acid monoanhydride, diethylenetriaminepentaacetic acid dianhydride, 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic dianhydride, or 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid monoanhydride; and

wherein the polyaminopolycarboxylic group of both said acid and said acid anhydride are the same.

16. A process for producing an amide compound, which comprises reacting a compound having an amino group with a polyaminopolycarboxylic acid anhydride in the presence of the polyaminopoilycarboxylic acid; wherein the polyaminopolycarboxylic acid is ethylenediamine-tetraacetic acid, diethylenetriamine-pentaacetic acid, or 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid,

wherein the polyaminopdycarboxylic acid anhydride is added to a mixture of the compound having an amino group and the polyaminopolycarboxylic acid, or the compound having an amino group and the polyaminopolycarboxylic acid anhydride are added to the polyaminopolycarboxylic acid; and

wherein the polyaminopolycarboxylic group of both said acid and said acid anhydride are the same.

17. A process for producing an amide compound, which comprises reacting a compound having an amino group with a polyaminopolycarboxylic acid anhydride in the presence of the polyaminopolycarboxylic acid and a base,

wherein the polyaminopolycarboxylic acid anhydride is added to a mixture of the compound having an amino group and the polyaminopolycarboxylic acid, or the compound having an amino group and the polyaminopolycarboxylic acid anhydride are added to the polyaminopolycarboxylic acid,

wherein the polyaminopolycarboxylic acid anhydride is ethylenediaminetetraacetic dianhydride, ethylenediaminetetraacetic acid monoanhydride, diethylenetriaminepentaacetic acid dianhydride, 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic dianhydride, or 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid monoanhydride; and

wherein the polyaminopolycarboxylic group of both said acid and said acid anhydride are the same.

Assignments (3)
CHANGE OF ADDRESS Recorded May 8, 2008
From: SUMITOMO CHEMICAL COMPANY, LIMITED
To: NIHON MEDI-PHYSICS COMPANY, LIMITED
Reel/Frame 020917/0163 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 2, 2004
From: SUMITOMO CHEMICAL COMPANY LIMITED
To: NIHON MEDI-PHYSICS COMPANY LIMITED
Reel/Frame 015658/0347 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 17, 2001
From: TAKANO, NAOYUKI; NAKAMURA, DAISAKU
To: SUMITOMO CHEMICAL COMPANY, LIMITED; NIHON MEDI-PHYSICS COMPANY, LIMITED
Reel/Frame 012264/0816 →
Priority Claims (1)
JP 2000-310626 · Oct 11, 2000 · national
Continuity (1)
Related Publication 20020077456A1 · Jun 20, 2002